http://www.ft.com/companies/healthhttp://www.ft.com/rss/companies/healthFT.com - Healthen© Copyright The Financial Times Ltd 2010. "FT" and "Financial Times" are trademarks of the Financial Times. See http://www.ft.com/servicestools/help/terms#legal1 for the terms and conditions of reuse.client.support@ft.com (Client Support)Wed, 10 Feb 2010 00:06:54 +0000Wed, 10 Feb 2010 06:25:37 +0000Newspapers15http://news.ft.com/cms/d1f3ce1a-6bbe-11da-bb53-0000779e2340.gifhttp://www.ft.com/companies/health(PICS-1.1 "http://www.classify.org/safesurf/" L gen true for "http://www.ft.com/" r (SS~~000 1))http://traxfer.ft.com/cms/s/0/ee44e6aa-15b3-11df-ad7e-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/ee44e6aa-15b3-11df-ad7e-00144feab49a.htmlThe UK Gene Therapy Advisory Committee has given approval for the company to begin the world's first human test of stem cell therapy with a dozen stroke patients Wed, 10 Feb 2010 00:06:54 +0000ee44e6aa-15b3-11df-ad7e-00144feab49ahttp://traxfer.ft.com/cms/s/0/613e6410-15a0-11df-ad7e-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/613e6410-15a0-11df-ad7e-00144feab49a.htmlThe court of appeal upheld a plea by Eli Lilly challenging patents filed on the sequence of the protein neutrokine-alpha identified by scanning the human genome for potential applicationsTue, 9 Feb 2010 23:08:55 +0000613e6410-15a0-11df-ad7e-00144feab49ahttp://traxfer.ft.com/cms/s/0/ae41e3ce-149a-11df-9ea1-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/ae41e3ce-149a-11df-9ea1-00144feab49a.htmlThe speciality drug company is to buy the bulk of Cambridge Laboratories in a deal valued at between £14m and £16m that will be part-funded with a share placing by AllianceMon, 8 Feb 2010 22:32:16 +0000ae41e3ce-149a-11df-9ea1-00144feab49ahttp://traxfer.ft.com/cms/s/0/ecfc80e2-1413-11df-8847-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/ecfc80e2-1413-11df-8847-00144feab49a.htmlThe German bandages maker has become the latest private equity-owned company to prepare for an initial public offeringMon, 8 Feb 2010 01:44:25 +0000ecfc80e2-1413-11df-8847-00144feab49ahttp://traxfer.ft.com/cms/s/0/503e764c-1414-11df-8847-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/503e764c-1414-11df-8847-00144feab49a.htmlThe scheme will link the pharmaceutical group directly with patients in many of the world's fastest-growing economies, a move that could boost use of its high-priced medicinesMon, 8 Feb 2010 01:43:33 +0000503e764c-1414-11df-8847-00144feab49ahttp://traxfer.ft.com/cms/s/0/103e87d2-11c4-11df-9d45-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/103e87d2-11c4-11df-9d45-00144feab49a.htmlGlaxoSmithKline is to stop researching antidepressant medicines as part of a shake up in research and development designed to strengthen productivityThu, 4 Feb 2010 20:47:22 +0000103e87d2-11c4-11df-9d45-00144feab49ahttp://traxfer.ft.com/cms/s/0/d104345c-1184-11df-9195-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/d104345c-1184-11df-9195-00144feab49a.htmlSurging sales in emerging markets as well as greater demand for vaccines have helped GlaxoSmithKline to compensate for declining revenues in the USThu, 4 Feb 2010 14:25:42 +0000d104345c-1184-11df-9195-00144feab49ahttp://traxfer.ft.com/cms/s/0/7c92f896-10e8-11df-9a9e-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/7c92f896-10e8-11df-9a9e-00144feab49a.htmlThe world's largest pharmaceutical group posts fourth-quarter profits up sharply to $767m but has lowered its guidance for 2012 after the patents on its best-selling drug expiresWed, 3 Feb 2010 23:58:36 +00007c92f896-10e8-11df-9a9e-00144feab49ahttp://traxfer.ft.com/cms/s/0/365d806c-10ed-11df-9a9e-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/365d806c-10ed-11df-9a9e-00144feab49a.htmlA road accident victim, presumed by his doctors to be in a persistent vegetative state, has answered simple questions by using thought alone, neuroscientists report Wed, 3 Feb 2010 22:18:25 +0000365d806c-10ed-11df-9a9e-00144feab49ahttp://traxfer.ft.com/cms/s/0/93bae8e4-1093-11df-975e-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/93bae8e4-1093-11df-975e-00144feab49a.htmlFull-year net profits at the Swiss pharmaceutical group fall 22% as it is hit by one-off costs relating to the $47bn acquisition of minority shares in US subsidiary Genentech Wed, 3 Feb 2010 07:46:22 +000093bae8e4-1093-11df-975e-00144feab49ahttp://traxfer.ft.com/cms/s/0/7d74f256-103d-11df-841f-00144feab49a.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/7d74f256-103d-11df-841f-00144feab49a.htmlThe research paper that triggered claims linking autism to the vaccine for measles, mumps and rubella has been retracted by the Lancet, the medical journal that published it more than a decade agoTue, 2 Feb 2010 21:03:16 +00007d74f256-103d-11df-841f-00144feab49ahttp://traxfer.ft.com/cms/s/0/2ed73272-0eb6-11df-bd79-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/2ed73272-0eb6-11df-bd79-00144feabdc0.htmlShift from developing drugs in-house to purchasing experimental products from smaller rivals would lift success rates, lower costs and triple returnsSun, 31 Jan 2010 22:46:04 +00002ed73272-0eb6-11df-bd79-00144feabdc0http://traxfer.ft.com/cms/s/0/d0b8b1a2-0e83-11df-bd79-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/d0b8b1a2-0e83-11df-bd79-00144feabdc0.htmlFall in GSK's headcount in its western pharmaceutical operations to be offset by fresh recruitment in emerging markets and non-pharmaceutical operationsSun, 31 Jan 2010 22:36:54 +0000d0b8b1a2-0e83-11df-bd79-00144feabdc0http://traxfer.ft.com/cms/s/0/69c3d686-0d0f-11df-a2dc-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/69c3d686-0d0f-11df-a2dc-00144feabdc0.htmlThe UK-based health and beauty retailer is to become the latest company to close its final-salary pension scheme to existing membersFri, 29 Jan 2010 20:10:34 +000069c3d686-0d0f-11df-a2dc-00144feabdc0http://traxfer.ft.com/cms/s/0/13ac30f8-0c75-11df-a941-00144feabdc0.html?o=%2Frss%2Fcompanies%2Fhealthhttp://www.ft.com/cms/s/0/13ac30f8-0c75-11df-a941-00144feabdc0.htmlThe British Medical Association has fired a broadside at government plans to give patients a completely free choice of family doctor, warning that the proposals could...Fri, 29 Jan 2010 02:00:00 +000013ac30f8-0c75-11df-a941-00144feabdc0